Arterra Bioscience SpA ( (IT:ARBS) ) just unveiled an announcement.
Arterra Bioscience S.p.A. reported a 6.37% increase in production value for 2024, driven by a 33.7% rise in sales of cosmetic raw materials. The company achieved a net profit of Euro 1.3 million, marking a 24.21% year-over-year growth. The Board of Directors proposed allocating profits to reserves and dividends, reflecting confidence in future growth, as indicated by the CEO’s optimism about 2025’s prospects.
More about Arterra Bioscience SpA
Arterra Bioscience S.p.A. is a green biotech company focused on research and development in biotechnology. It has been listed on the Euronext Growth Milan market of Borsa Italiana since 2019 and specializes in producing cosmetic raw materials.
YTD Price Performance: 8.16%
Average Trading Volume: 7,350
Technical Sentiment Signal: Sell
Current Market Cap: €14.12M
For an in-depth examination of ARBS stock, go to TipRanks’ Stock Analysis page.